Literature DB >> 3297155

Glycosphingolipids and antitumor immunity.

E V Dyatlovitskaya, L D Bergelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297155     DOI: 10.1016/0304-419x(87)90002-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  12 in total

Review 1.  Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

Authors:  Keqiang Chen; Ji Ming Wang; Ruoxi Yuan; Xiang Yi; Liangzhu Li; Wanghua Gong; Tianshu Yang; Liwu Li; Shaobo Su
Journal:  Int Immunopharmacol       Date:  2016-02-22       Impact factor: 4.932

Review 2.  Aglycone modulation of glycolipid receptor function.

Authors:  C A Lingwood
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Ganglioside incorporation and release by the isolated perfused rat liver.

Authors:  S C Kivatinitz; A Miglio; R Ghidoni
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

4.  Inhibition of human peripheral blood mononuclear cell proliferative response by glycosphingolipids from metacestodes of Echinococcus multilocularis.

Authors:  F Persat; C Vincent; D Schmitt; M Mojon
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; F Unland; J Lehmann
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

6.  Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.

Authors:  J W Chu; F J Sharom
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Monoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells.

Authors:  K Ding; T Ekberg; J Zeuthen; S Teneberg; K A Karlsson; A Rosén
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

Review 8.  Gangliosides and antitumor immunity.

Authors:  L D Bergelson
Journal:  Clin Investig       Date:  1993-08

9.  Gangliosides are potent immunosuppressors of IL-2-mediated T-cell proliferation in a low protein environment.

Authors:  P Lu; F J Sharom
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

Review 10.  Gangliosides and atherosclerosis.

Authors:  N V Prokazova; L D Bergelson
Journal:  Lipids       Date:  1994-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.